Standout Papers

Detection of large-scale variation in the human genome 2004 2026 2011 2018 2.1k
  1. Detection of large-scale variation in the human genome (2004)
    A. John Iafrate, Lars Feuk et al. Nature Genetics
  2. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases (2014)
    Shengdar Q. Tsai, Zongli Zheng et al. Nature Biotechnology
  3. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK (2009)
    Alice T. Shaw, Beow Y. Yeap et al. Journal of Clinical Oncology
  4. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells (2008)
    Shyamala Maheswaran, Lecia V. Sequist et al. New England Journal of Medicine
  5. Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers (2012)
    Ryohei Katayama, Alice T. Shaw et al. Science Translational Medicine
  6. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (2021)
    Wilfredo F. García-Beltrán, Evan C. Lam et al. Cell
  7. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations (2008)
    Lecia V. Sequist, Renato Martins et al. Journal of Clinical Oncology
  8. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant (2022)
    Wilfredo F. García-Beltrán, Kerri St. Denis et al. Cell
  9. Anchored multiplex PCR for targeted next-generation sequencing (2014)
    Zongli Zheng, Matthew Liebers et al. Nature Medicine
  10. Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping (2011)
    Darrell R. Borger, Kenneth K. Tanabe et al. The Oncologist
  11. Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Population (2009)
    Scott J. Rodig, Mari Mino–Kenudson et al. Clinical Cancer Research
  12. Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma (2011)
    Matija Snuderl, Ladan Fazlollahi et al. Cancer Cell
  13. ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer (2013)
    Justin F. Gainor, Anna M. Varghese et al. Clinical Cancer Research
  14. Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 (2019)
    A. Shaw, Yung‐Jue Bang et al. Annals of Oncology
  15. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals (2022)
    Vivek Naranbhai, Anusha Nathan et al. Cell

Immediate Impact

7 by Nobel laureates 54 from Science/Nature 106 standout
Sub-graph 1 of 15

Citing Papers

Improving prime editing with an endogenous small RNA-binding protein
2024 StandoutNature
Structural basis for mismatch surveillance by CRISPR–Cas9
2022 StandoutNature

Works of A. John Iafrate being referenced

GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
2014 Standout

Author Peers

Author Last Decade Papers Cites
A. John Iafrate 11427 10458 11135 238 26.5k
Ash A. Alizadeh 8371 10763 15023 243 34.2k
William C. Hahn 4805 11079 26136 289 40.1k
Charles Swanton 8250 12369 12617 314 29.4k
Maximilian Diehn 9372 8972 11797 261 26.7k
José Baselga 13302 34173 17049 270 48.4k
Claudio Doglioni 5595 11430 8469 469 26.2k
Timothy A. Chan 5373 10078 9193 241 22.0k
Lieping Chen 6457 33760 9061 366 54.6k
Martin Gore 8895 14140 12791 377 29.0k
Charles Lee 5484 5804 14336 304 27.3k

All Works

Loading papers...

Rankless by CCL
2026